IPBS Toulouse
@ipbstoulouse.bsky.social
590 followers 260 following 55 posts
Better understanding towards better therapeutics in #Cancer, #Infection and #Inflammation (@cnrs.bsky.social et Université de Toulouse) in #Toulouse https://www.ipbs.fr
Posts Media Videos Starter Packs
Reposted by IPBS Toulouse
Reposted by IPBS Toulouse
oneyrolles.bsky.social
Excited to share Wendy Le Mouëllic’s PhD work, now published in @pnas.org!
It reveals that M. tuberculosis depends on inorganic sulfate import to survive inside host cells—fueling essential processes such as redox balance and stress resistance.
Huge congrats to Wendy & colleagues!
shorturl.at/WbFQC
Inorganic sulfate is critical for Mycobacterium tuberculosis lung tissue colonization and redox balance | PNAS
Tuberculosis remains the deadliest infectious disease caused by a single pathogen, highlighting the urgent need for novel therapies. A deeper under...
www.pnas.org
Reposted by IPBS Toulouse
oneyrolles.bsky.social
Another memorable #TBVACHORIZON WP1 working group meeting in Basel, Switzerland! Grateful to #TBVI and many thanks to Daniel Pinschewer and colleagues for the warm welcome and inspiring discussions.
@unibas.ch @horizoneu.bsky.social
Reposted by IPBS Toulouse
danbarberphd.bsky.social
We are looking to hire post-docs to work on T cell responses to M. tuberculosis infection using murine and NHP models. If you know T cells and wanna work on the top global infectious killer check us out. BSL3 experience not required. The NIH intramural program in Bethesda MD is an amazing place!
ipbstoulouse.bsky.social
From tuberculosis to rheumatoid arthritis: A glycobiology breakthrough enters the valorization phase
👏 @yoannrombouts.bsky.social
Thanks @frm-officiel.bsky.social
More info: shorturl.at/i3sQd
ipbstoulouse.bsky.social
Big news from IPBS! Our researchers are coordinators or partners in 8 cutting-edge projects funded by @agencerecherche.bsky.social

From DNA vaccine electroporation to drug-resistant pathogens, bone health, allergy, and proteasomes, IPBS is driving innovation in biomedicine!
urls.fr/gt6JZf
ipbstoulouse.bsky.social
Congratulations to all the newly elected @embo.org members.

A special shout-out to our SAB member, Wolf-Dietrich Hardt, on this well-deserved recognition!

Outstanding life scientists elected to the EMBO Membership – Press releases – www.embo.org/press-releas...
Outstanding life scientists elected to the EMBO Membership – Press releases – EMBO
Sixty-nine new members join the community of leading life scientists in Europe and beyond
www.embo.org
Reposted by IPBS Toulouse
unglam.bsky.social
I'm thrilled to share that I’ve been selected for the #ATIP-Avenir 2025 Young Investigator Programme to support my new research group at @ipbstoulouse.bsky.social for the next 5 years! 🧑‍🔬🔬🦠🤩
ipbstoulouse.bsky.social
🎉🎉🎉 Big congrats to Kien Lam UNG, recipient of the 2025 #ATIP-Avenir award!
From decoding antibiotic resistance in M. abscessus to revealing plant hormone transporters in Nature, he is now launching a bold project on how sugar tweaks shape host–pathogen battles. Sweet science! 👏👏👏

shorturl.at/TJiHg
Kien Lam UNG is a recipient of the 2025 ATIP-Avenir program - IPBS-Toulouse
Kien Lam UNG obtained his PhD from the University of Montpellier, where he worked on[…]
shorturl.at
ipbstoulouse.bsky.social
🎉🎉🎉 Big congrats to Kien Lam UNG, recipient of the 2025 #ATIP-Avenir award!
From decoding antibiotic resistance in M. abscessus to revealing plant hormone transporters in Nature, he is now launching a bold project on how sugar tweaks shape host–pathogen battles. Sweet science! 👏👏👏

shorturl.at/TJiHg
Kien Lam UNG is a recipient of the 2025 ATIP-Avenir program - IPBS-Toulouse
Kien Lam UNG obtained his PhD from the University of Montpellier, where he worked on[…]
shorturl.at
Reposted by IPBS Toulouse
oneyrolles.bsky.social
Honored to award the title of Dr. honoris causa of the University of Toulouse to Dr. Manjula Reddy (CCMB, Hyderabad).
A world-renowned microbiologist, Dr. Reddy has made major contributions to our understanding of bacterial cell division. 🇫🇷🇮🇳
Reposted by IPBS Toulouse
cnrsbiologie.bsky.social
🚀 Découvrez notre kit de démarrage avec une liste des acteurs de l’Enseignement Supérieur et de la Recherche (ESR) déjà présents sur la plateforme ! 🧑‍🎓🔬

🌟 Cette liste sera régulièrement mise à jour au fil des nouvelles arrivées !

🔗 go.bsky.app/S1tY1ws

#VeilleESR #ESR
Reposted by IPBS Toulouse
pierredupuy.bsky.social
After a PhD and two postdocs, I’m very proud to be joining the CNRS as a Chargé de recherche, this is a meaningful milestone. Huge thanks to Claude Bruand, @michaelglickman.bsky.social, and @oneyrolles.bsky.social for their guidance and support. Olivier, let’s turn this into exciting discoveries!
ipbstoulouse.bsky.social
Congrats Pierre! And welcome to the family! 😉
ipbstoulouse.bsky.social
🏳️‍🌈 For the 3rd year in a row, IPBS proudly kicks off #PrideMonth by reaffirming our year-round commitment to inclusion, equity & respect. Diversity drives science, and we celebrate every identity that makes our institute stronger.
💪 #LGBTQIA #InclusionMatters #PrideAtIPBS

shorturl.at/eyTei
Celebrating Diversity and Inclusion at IPBS – Pride Month 2025 - IPBS-Toulouse
For the third consecutive year, the IPBS proudly reaffirms its commitment to fostering an inclusive,[…]
shorturl.at
Reposted by IPBS Toulouse
oneyrolles.bsky.social
Thrilled to host our Indian colleagues for the first MIRA workshop, the @cnrsbiologie.bsky.social International Research Network on #AMR that I co-coordinate with the amazing Amit Singh! 🇮🇳🇫🇷

Huge thanks to @isabellesaves.bsky.social and team for the stellar organization! #MicroSky
ipbstoulouse.bsky.social
In @cp-cellrepmed.bsky.social, IPBS researchers propose a treatment based on optimized antibodies that, in mice, increases the proportion of HEV blood vessels and facilitates killer cell entry into tumors.
These molecules are currently in clinical trials ⤵️
buff.ly/Ip3US2l
Reposted by IPBS Toulouse
cnrsbiologie.bsky.social
Dans‪ @cp-cellrepmed.bsky.social, des chercheurs proposent un traitement à base d’anticorps optimisés qui, chez la souris, augmente la proportion des vaisseaux sanguins HEV et facilite l’entrée des cellules tueuses dans les tumeurs. Ces molécules sont en essai clinique ⤵️

buff.ly/w2dk30U
Un nouvel anticorps pour améliorer l’efficacité de l’immunothérapie
L’immunothérapie est un traitement révolutionnaire dans la lutte contre le cancer. Mais son efficacité doit être renforcée.
buff.ly
Reposted by IPBS Toulouse
ipbstoulouse.bsky.social
🌏Social Event – Infectious diseases & antimicrobial resistance workshop
Yesterday, participants enjoyed a boat cruise along the Canal du Midi in Toulouse.
A great opportunity to discover the city, exchange ideas on cutting-edge research, and build international connections.
🔗 www.ipbs.fr/mira2025/